TYG offers high income and diversified exposure to energy infrastructure, including both MLPs and corporations. Check out my ...

Viking Therapeutics (VKTX) stock gains as Roche (RHHBY) and Zealand Pharma's (ZLDPF) $5.3B deal for obesity drugs lifts ...

Montea (MONSF) aims to increase earnings to 5.60 EUR per share by 2027. Read why I remain bullish on the stock.

Quantum-Si's next-gen protein sequencing tech and growth partnerships show promise, but high costs, financial risks, and ...

Eaton ( NYSE: ETN) late Tuesday was upgraded to Overweight from a previous rating of Sector Weight by analysts at KeyBanc ...

Growth stocks have outperformed since 2020, but Value stocks excel in bear markets. Read why I'm bullish on iShares S&P 500 ...

The Consumer Price Index for February rose by 0.2 percent (expectations of 0.3 percent and 0.5 percent) last month. Click to ...

Roche & Zealand Pharma join forces on petrelintide, advancing obesity treatments with innovative amylin analogs. See why this ...

Tesla, Inc.'s stock faces pressure from declining fundamentals, Musk's polarizing actions, and overvaluation concerns. Click ...

Potential investors for PLTR are probably tempted to bottom fish amid the recent selloff. However, my technical analysis ...

While Nvidia has been the undisputed winner in the AI boom, the market is shifting its focus beyond chipmakers to companies ...

Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, ...